How Widespread is Mask-Wearing in Washington? UW Study Aims to Find Out, Starting in King County (includes Judith Wasserheit and Brandon Guthrie)

By Sandi Doughton Seattle Times staff reporter

We’ve all noticed that fellow shopper at the grocery store with a mask snugged over his mouth — but not his nose. Maybe you’ve also got a neighbor who tugs her mask down to talk. Or perhaps you’ve detoured around groups of barefaced teenagers jostling each other in a park.

COVID-19: CDC Advisory Committee Hones in on Vaccine Rollout Recommendations (includes Beth Bell)

Jake EllisonUW News

When a vaccine to fight COVID-19 has been approved by the FDA for distribution, it’s unlikely that at first there will be enough doses for everyone. Consequently, the United States will need an equitable and effective plan for who gets those first doses, how they get them and who’s next.

Just as important, that plan — like the vaccine itself — has to be trusted and accepted by the general public.

Evidence Related to Schools During the COVID-19 Pandemic

Most countries world-wide implemented localized or national school closures in response to the COVID-19 pandemic, with estimates of >65% of enrolled children globally affected by school closures.1 Since the early pandemic, schools in many settings around the world have fully or partially re-opened for in-person instruction, while in other settings schools have re-opened exclusively using online learning.

Researchers Recruiting Patients for Regeneron Antibody Trial (includes Ruanne Barnabas)

UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.

Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.

How COVID-19 Affects Some People Long After They Become Infected with the Coronavirus (includes Jennifer Ross)

By Ryan Blethen Seattle Times staff reporter

Nearly eight months after the pandemic was declared, researchers are gaining a more complete understanding of how the new coronavirus affects people.

One thing they’re noticing as time goes on: some people diagnosed with COVID-19 feel sick long after contracting the virus.

Summary of COVID-19 Long-term Health Effects: Emerging Evidence and Ongoing Investigation

Understanding the course of patients’ recovery from COVID-19 is critical for health system planning and for guiding public health prevention efforts. At less than one year into the COVID-19 pandemic, many long-term effects of SARS-CoV-2 infection remain unknown. However, new evidence is emerging rapidly about symptom profiles and rehabilitation needs of COVID-19 survivors in the initial months of their recovery. This document is a brief summary of published evidence about the sequelae of COVID-19 and ongoing studies of its long-term health effects.

Making Crowded Spaces Safer - Health Alliance International

New partnership to give Mozambique’s highest risk spaces a new attitude toward COVID-19

As COVID-19 cases climb in South Africa, neighboring Mozambique’s Ministry of Health, with support from Health Alliance International & Vital Strategies, is working to transform public spaces from high-risk to high-compliance when it comes to protecting against community transmission of COVID-19.

Pages